Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Indexed In
- RefSeek
- Hamdard University
- EBSCO A-Z
- Publons
Useful Links
Recommended Journals
Related Subjects
Share This Page
Aim and Scope
| » | Advances in Molecular Diagnostics, a broad-based journal was founded on a key tenet: To publish the most exciting researches with respect to the subjects of Molecular Diagnostics. Secondly, to provide a rapid turn-around time possible for reviewing and publishing and to disseminate the articles freely for research, teaching and reference purposes. |
» |
In today's wired world information is available at the click of the button, courtesy the Internet. Molecular Diagnostics-Open Access gives a world wide audience larger than that of any subscription-based journal in OMICS field, no matter how prestigious or popular, and probably increases the visibility and impact of published work. Advances in Molecular Diagnostics- Open Access gives barrier-free access to the literature for research. It increases convenience, reach, and retrieval power. Free online literature is available for software that facilitates full-text searching, indexing, mining, summarizing, translating, querying, linking, recommending, alerting, mash-ups and other forms of processing and analysis. Advances in Molecular Diagnostics- Open Access puts rich and poor on an equal footing for these key resources and eliminates the need for permissions to reproduce and distribute content. |
» |
OMICS Group is ardent to Open Access. We strongly believe that removing barriers to research published online will greatly aid to the progress in OMICS scientific and technical disciplines. |
» |
All published articles will be assigned DOI provided by CrossRef. Advances in Molecular Diagnostics will keep upto date with latest advances in the field and papers published in Dermatology will reach the readers directly by email for free of cost. |
» |
Distributed widely through the Internet. |
» |
Archived online in the transactions of the OMICS Group, which provides the international scientific community with immediate and permanent access to individual papers. |
» |
Dermatology Case Reports accepts online letters to the editors and brief comments that contributes to the previously published articles or other relevant findings in OMICS field. |
» |
Open Access is a publication model, that enables the dissemination of research articles to the global community without restriction usually through the internet. Thus, all articles published under Open Access can be accessed by anyone with internet connection. Dermatology Case Reports strongly supports the Open Access initiative. Abstracts and full texts (HTML, PDF and XML format) of all articles published by Dermatology Case Reports are freely accessible to everyone immediately after publication. |
» |
All works published by OMICS Group are under the terms of the Creative Commons Attribution License. This permits anyone to copy, distribute, transmit and adapt the work provided the original work and source is appropriately cited. Advances in Molecular Diagnostics supports the Bethesda Statement on Open Access Publishing. |
Definition of Open Access Publication |
|
» |
An Open Access Publication is one that meets the following two conditions: |
|
|
| » | As a member of Publisher International linking Association, PILA, Advances in Molecular Diagnostics (of OMICS International) follows the Creative Commons Attribution License and Scholars Open Access publishing policies. |
Note: |
|
» |
Community standards, rather than copyright law, will continue to provide the mechanism for enforcement of proper attribution and responsible use of the published work, as they do now. |
